Alida Reinoso
Miami, FLNPI 1831358233
Payments from drug & device makers
$3,371,220in general payments, 2019–2025
Across 721 payments — averaging $4675.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.2M
- AbbVie$1.1M
- Supernus Pharmaceuticals, Inc.$56K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 558 | $2,209,350 |
| AbbVie(2 entities) | 155 | $1,106,255 |
| Supernus Pharmaceuticals, Inc. | 8 | $55,616 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.